It falls into the general health bucket, and using your HSA for it would be a violation that comes with taxes and penalties
Semaglutide is an oral agonist of glucagon-like peptide-1 receptor (GLP1R) , used for treating type 2 diabetes and obesity by enhancing insulin secretion, reducing glucagon levels, and promoting weight loss
When to Seek Immediate Medical Attention Contact your healthcare provider or seek emergency care if you experience: Severe abdominal pain that does not go away Signs of an allergic reaction (rash, swelling, difficulty breathing) Symptoms of pancreatitis (severe abdominal pain, vomiting) Symptoms of severe dehydration (dizziness, confusion, rapid heartbeat) FDA Adverse Event Reporting
However, DPP-4 inhibitors (such as sitagliptin or linagliptin) should be discontinued when initiating semaglutide, as both drug classes work through incretin pathways, and combined use offers no additional glycemic benefit while potentially increasing adverse effects
This FDA approval is the culmination of years of technical research and rigorous clinical studies, said Lara Barghout, President and CEO of Recor Medical
Mistake 1: wrong reconstitution volume This is the most common and most consequential error